CUOMO, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 4.705
NA - Nord America 4.504
AS - Asia 2.781
SA - Sud America 724
AF - Africa 126
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.876
Nazione #
US - Stati Uniti d'America 4.387
IT - Italia 1.217
RU - Federazione Russa 1.043
SG - Singapore 914
GB - Regno Unito 906
CN - Cina 851
BR - Brasile 590
IE - Irlanda 535
VN - Vietnam 246
HK - Hong Kong 228
SE - Svezia 228
KR - Corea 182
DE - Germania 157
FR - Francia 156
UA - Ucraina 118
IN - India 107
FI - Finlandia 85
CA - Canada 64
TR - Turchia 60
AR - Argentina 57
ES - Italia 44
NL - Olanda 43
MX - Messico 38
BD - Bangladesh 36
KE - Kenya 33
PL - Polonia 32
ZA - Sudafrica 30
AT - Austria 28
AU - Australia 26
JP - Giappone 23
CI - Costa d'Avorio 22
EC - Ecuador 20
CH - Svizzera 19
IQ - Iraq 19
PE - Perù 18
ID - Indonesia 15
CZ - Repubblica Ceca 11
GR - Grecia 11
MY - Malesia 11
EG - Egitto 10
HU - Ungheria 10
IR - Iran 10
PH - Filippine 10
VE - Venezuela 10
UZ - Uzbekistan 9
CL - Cile 8
CO - Colombia 8
PK - Pakistan 8
PT - Portogallo 8
SA - Arabia Saudita 8
IM - Isola di Man 7
TH - Thailandia 7
UG - Uganda 7
DK - Danimarca 6
LT - Lituania 6
PY - Paraguay 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
BE - Belgio 5
DZ - Algeria 5
MA - Marocco 5
NZ - Nuova Zelanda 5
RO - Romania 5
AZ - Azerbaigian 4
BG - Bulgaria 4
JO - Giordania 4
KG - Kirghizistan 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
BF - Burkina Faso 3
CR - Costa Rica 3
IL - Israele 3
JM - Giamaica 3
KW - Kuwait 3
NG - Nigeria 3
NP - Nepal 3
PR - Porto Rico 3
TN - Tunisia 3
BH - Bahrain 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
PS - Palestinian Territory 2
SI - Slovenia 2
SV - El Salvador 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
Totale 12.866
Città #
Southend 771
Dallas 724
Dublin 526
Singapore 457
Ashburn 360
Fairfield 357
Santa Clara 343
Moscow 334
Houston 263
Beijing 237
Siena 226
Hefei 222
Hong Kong 217
Chandler 190
Seoul 174
Woodbridge 158
Florence 147
Wilmington 140
Seattle 117
Cambridge 115
Milan 107
Jacksonville 102
Princeton 78
Los Angeles 72
Dong Ket 71
Ann Arbor 63
Rome 62
São Paulo 62
Ho Chi Minh City 57
New York 56
Helsinki 51
Munich 48
Redondo Beach 41
Council Bluffs 40
Bengaluru 39
Hanoi 36
The Dalles 36
Nairobi 33
Nanjing 33
Rio de Janeiro 32
San Diego 31
Buffalo 30
San Mateo 29
Málaga 24
Abidjan 22
Boardman 22
Brescia 22
London 22
Nuremberg 21
Sanliurfa 21
Washington 21
Brooklyn 19
Warsaw 19
Bologna 17
Chicago 17
Lappeenranta 17
San Francisco 17
Prato 16
Trento 16
Vienna 16
Campinas 15
Columbus 15
Dhaka 14
Lima 14
Montreal 14
Mumbai 14
Naples 14
Tianjin 14
Tokyo 14
Turin 14
Amsterdam 13
Cape Town 13
Livorno 13
Stockholm 13
Belo Horizonte 12
Johannesburg 12
Manchester 12
Norwalk 12
Boston 11
Da Nang 11
Denver 11
Padova 11
Turku 11
Guangzhou 10
Newark 10
Palermo 10
Shanghai 10
West Roxbury 10
Atlanta 9
Curitiba 9
Palazzolo sull'Oglio 9
Sydney 9
Tashkent 9
Zurich 9
Biên Hòa 8
Chennai 8
Madrid 8
Melbourne 8
Nanchang 8
Orem 8
Totale 8.065
Nome #
Trazodone: a multifunctional antidepressant. Evaluation of its properties and real-world use 549
Clinical effectiveness of parenteral trazodone for the management of psychomotor activation in patients with bipolar disorder 503
Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice 377
"TREATMENT-RESISTANT DEPRESSION" AND USE OF INTRAVENOUS KETAMINE AND INTRANASAL ES-KETAMINE 344
Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder 329
Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice 288
Antidepressant and pro-motivational effects of repeated lamotrigine treatment in a rat model of depressive symptoms 275
Drug safety evaluation of aripiprazole in bipolar disorder 237
The Microbiome: A New Target for Research and Treatment of Schizophrenia and its Resistant Presentations? A Systematic Literature Search and Review 234
Advances in treatment for postpartum major depressive disorder 216
Feasibility, adherence and efficacy of liraglutide treatment in a sample of individuals with mood disorders and obesity 215
Prevalence and correlates of Vitamin D deficiency in a sample of 290 inpatients with mental illness 208
Does higher severity really correlate with a worse quality of life in obsessive-compulsive disorder? A meta-regression 194
Pharmacotherapeutic strategies for treating binge eating disorder. Evidence from clinical trials and implications for clinical practice 193
Prevalence, chronicity, burden and borders of bipolar disorder 186
A new approach for seasonal pattern: is it related to bipolarity dimension? Findings from an Italian multicenter study 184
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 183
Internet use by older adults with bipolar disorder: international survey results 178
Mood spectrum symptoms during a major depressive episode: Differences between 145 patients with bipolar disorder and 155 patients with major depressive disorder. Arguments for a dimensional approach 178
The neural bases of social cognition in major depressive disorder: a review [La cognizione sociale nel disturbo depressivo maggiore: Una rassegna sulle basi neurali] 175
S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): A clinician-oriented systematic review 175
Using sertraline in postpartum and breastfeeding: balancing risks and benefits 174
On the centrality of mixed features in mood disorders: Listening to Kraepelin and Weygandt and moving forward 170
Perfenazina, amitriptilina e perfenazina-amitriptilina: Ruolo nella pratica clinica [Perphenazine, amitriptyline and perphenazine-amitriptyline: Role in clinical practice] 166
Effectiveness of light therapy as adjunctive treatment in bipolar depression: A pilot study 166
Accuracy of self-assessment of real-life functioning in schizophrenia 162
Mental health in Italy after two years of COVID-19 from the perspective of 1281 Italian physicians: looking back to plan forward 160
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 160
Biomarkers, Inflammation, and Bipolar Disorder: Association Between the Improvement of Bipolar Disorder Severity and the Improvement in C-Reactive Protein Levels After 7 Days of Inpatient Treatment 159
A Systematic Review on Ketamine and Esketamine for Treatment-Resistant Depression and Suicidality in Adolescents: A New Hope? 157
Treatment persistence in patients with schizophrenia treated with lurasidone in Italian clinical practice 152
Neuroticism and conscientiousness moderate the effect of oral medication beliefs on adherence of people with mental illness during the pandemic 151
Exploring treatment strategies for mood stabilization in patients with major depressive disorder and mixed features 147
Therapeutic Potential of Saffron Extract in Mild Depression: A Study of Its Role on Anhedonia in Rats and Humans 146
The impact of COVID-19 pandemic in patients with a diagnosis of Oral Lichen Planus: Pain perception and psychological profile analysis 142
Five-year follow-up of first-episode depression treated with psychodynamic psychotherapy or antidepressants 141
La responsabilità dello psichiatra [Duties and liabilities for psychiatrists] 139
Safety of psychotropic medications in people with COVID-19: Evidence review and practical recommendations 138
COVID-19 Diary from a Psychiatry Department in Italy 136
null 134
Efficacy of topiramate in treating obsessive compulsive disorder: A systematic review and meta-analysis 133
Effectiveness and Tolerability of Supratherapeutic Dosing of Vortioxetine in Patients With Treatment-Resistant Depression 127
Clinical guidance for the use of trazodone in major depressive disorder and concomitant conditions: Pharmacology and clinical practice 127
Treating schizophrenia with cariprazine: from clinical research to clinical practice. Real world experiences and recommendations from an International Panel 127
Treating major depressive disorder with mixed features 125
Is intravenous valproate more efficacious than oral valproate for inpatients with bipolar I disorder with a manic or depressive episode and concomitant symptoms of opposite polarity? 125
Two-Injection Start Regimen of Long-Acting Aripiprazole in 133 Patients With Schizophrenia 124
Perspectives on the impact of vortioxetine on the treatment armamentarium of major depressive disorder 120
Validation of the Oxford Depression Questionnaire: Sensitivity to change, minimal clinically important difference, and response threshold for the assessment of emotional blunting 118
Exploration of mood spectrum symptoms during a major depressive episode: The impact of contrapolarity-Results from a transdiagnostic cluster analysis on an Italian sample of unipolar and bipolar patients 116
Psychological interventions for post-traumatic stress disorder in women survivors of intimate partner violence: A systematic review and meta-analysis 115
Practical guidance for prescribing trazodone extended-release in major depression 113
Effectiveness of Intramuscular Chlorpromazine for Rapid Treatment of Psychomotor Agitation: A Naturalistic, Retrospective, and Observational Study 110
Which mixed depression model? A comparison between DSM-5-defined mixed features and Koukopoulos' criteria 109
QTc interval diurnal variations in patients treated with psychotropic medications: implications for the evaluation of drug induced QTc changes 108
Symptom modulation and tolerability of intravenous ketamine in treatment-resistant bipolar depression: A retrospective study 106
Association between polarity of first episode and solar insolation in bipolar I disorder 105
Lamotrigine in bipolar disorder: preventing depression to treat the disease 105
Disorganization and real-world functioning in schizophrenia: Results from the multicenter study of the Italian Network for Research on Psychoses 101
Erratum: Safety of psychotropic medications in people with COVID-19: Evidence review and practical recommendations (BMC Medicine (2020) 18 (215) DOI: 10.1186/s12916-020-01685-9) 96
Personalized treatment of depression phenotypes: Role of trazodone in depression with insomnia 96
Exploratory study of ultraviolet B (UVB) radiation and age of onset of bipolar disorder 95
Worldwide prevalence of obsessive-compulsive symptoms during the COVID-19 pandemic: A systematic review and meta-analysis 94
Medico-legal implications of mobbing: a case law [Riflessioni medico-legali su un caso giudiziario di mobbing] 94
Vulnerabilities in Mental Health due to Covid-19 Pandemic: The Response of the Italian Physicians 93
The influence of autistic symptoms on social and non-social cognition and on real-life functioning in people with schizophrenia: Evidence from the Italian Network for Research on Psychoses multicenter study 93
Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release 93
Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis 92
Lurasidone in adolescents and adults with schizophrenia: from clinical trials to real-world clinical practice 90
Insights into the Incidence, Course, and Management of Lithium-Induced Hypothyroidism in Real-World Psychiatric Practice in Italy 90
Variations in seasonal solar insolation are associated with a history of suicide attempts in bipolar I disorder 90
Principi di farmacodinamica e farmacocinetica nello switch tra antipsicotici: focus su cariprazina 86
Investigating the Relationship between Autistic Traits, Ruminative Thinking, and Suicidality in a Clinical Sample of Subjects with Bipolar Disorder and Borderline Personality Disorder 86
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses 86
Drug-drug interactions between COVID-19 therapeutics and psychotropic medications 85
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis 84
Impact of menstrual cycle events on bipolar disorder course: a narrative review of current evidence 81
Treatment persistence with aripiprazole once monthly: a 4-year follow-up 80
Interplay Among Psychopathologic Variables, Personal Resources, Context-Related Factors, and Real-life Functioning in Individuals With Schizophrenia: A Network Analysis 79
Unraveling the Boundaries, Overlaps, and Connections between Schizophrenia and Obsessive–Compulsive Disorder (OCD) 79
Rethinking the role of trazodone in the different depressive dimensions 77
Autistic symptoms in unaffected first-degree relatives of people with schizophrenia: results from the Italian Network for Research on Psychoses multicenter study 77
Personalized medicine with extended-release trazodone and/or once-a-day trazodone: From research trials to clinical practice 77
Genome-wide association study detected novel susceptibility genes for social cognition impairment in people with schizophrenia 73
Individualized strategies for depression: narrative review of clinical profiles responsive to vortioxetine 72
Practical prescribing with COVID-19 medications and psychotropics: a guide to pharmacokinetic interactions 70
Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the "real-life" 66
Neurophysiological correlates of ketamine-induced dissociative state in bipolar disorder: insights from real-world clinical settings 64
Employment and Social Security/Insurance among patients affected by mental disorders in Italy: A descriptive multi-center study 61
Pocket Guide to Practical Psychopharmacology : Lithium and Anticonvulsants in Psychiatric Practice 54
Prolonged grief disorder in psychiatric patients: Assessing the PG-13-R scale and clinical implications 52
Liquid antipsychotics in the management of psychomotor agitation: a focus on promazine 42
Intravenous trazodone for the treatment of psychomotor agitation and associated symptoms in major depressive disorder patients experiencing a depressive episode with mixed features 36
Totale 13.218
Categoria #
all - tutte 41.991
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.991


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021905 0 0 0 0 0 88 130 129 109 216 73 160
2021/2022751 32 82 57 74 42 40 63 46 82 48 58 127
2022/2023937 55 60 133 86 58 151 29 143 95 44 39 44
2023/20241.378 77 36 96 90 50 284 341 42 18 99 113 132
2024/20253.334 112 146 227 329 366 283 143 141 255 255 347 730
2025/20264.101 546 892 653 785 1.042 183 0 0 0 0 0 0
Totale 13.218